IND-Enabling Studies of a Potent LpxC Inhibitor Targeting Multi-Drug Resistant Gram-Negative Bacteria
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Valanbio Therapeutics, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Clayton Duncan
Fiscal Year
2022
Region
Research Triangle
Project Description:
ValenBio is focused on developing drugs with a novel mode of action for treating infections caused by Gram-negative bacteria. The company has been awarded a SRL loan to complete formulation optimization, stability, and solubility studies for their lead candidate, VB-233.